Addus HomeCare (NASDAQ:ADUS) Price Target Raised to $150.00

Addus HomeCare (NASDAQ:ADUS) had its price target lifted by Oppenheimer from $145.00 to $150.00 in a research note published on Friday,Benzinga reports. Oppenheimer currently has an outperform rating on the stock.

Other analysts have also recently issued research reports about the stock. Stephens raised their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. JMP Securities started coverage on Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 price target on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. StockNews.com upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Friday. Finally, Macquarie restated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, nine have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $134.22.

Addus HomeCare Stock Up 2.8 %

Addus HomeCare stock opened at $130.62 on Friday. The business has a 50-day simple moving average of $126.10 and a 200 day simple moving average of $127.09. Addus HomeCare has a 52 week low of $85.94 and a 52 week high of $136.72. The stock has a market cap of $2.37 billion, a price-to-earnings ratio of 29.89, a PEG ratio of 1.73 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.03 earnings per share. On average, research analysts anticipate that Addus HomeCare will post 4.58 earnings per share for the current year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 39,750 shares of company stock worth $4,930,750. 4.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently bought and sold shares of the business. Wasatch Advisors LP raised its holdings in shares of Addus HomeCare by 11.8% during the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock valued at $138,782,000 after acquiring an additional 110,010 shares in the last quarter. Point72 Asset Management L.P. increased its position in Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after purchasing an additional 315,602 shares during the period. State Street Corp increased its position in Addus HomeCare by 4.4% during the 3rd quarter. State Street Corp now owns 663,610 shares of the company’s stock valued at $88,280,000 after purchasing an additional 27,990 shares during the period. Principal Financial Group Inc. raised its holdings in Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after purchasing an additional 75,409 shares in the last quarter. Finally, WCM Investment Management LLC lifted its position in shares of Addus HomeCare by 2.9% in the 3rd quarter. WCM Investment Management LLC now owns 498,279 shares of the company’s stock worth $65,250,000 after purchasing an additional 13,938 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.